In whom, how and how often is surveillance for hepatocellular carcinoma cost-effective?

Annals of hepatology : official journal of the Mexican Association of Hepatology

Volumn 3, Issue 4, 2004, Pages 152-159

  Ruelas Villavicencio, Ana Lilia ^a   Vargas Vorácková, Florencia ^a  

^a Department of Gastroenterology

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ARTICLE; COST BENEFIT ANALYSIS; DECISION TREE; ECHOGRAPHY; ECONOMICS; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MEXICO; MIDDLE AGED; MORTALITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; COST-BENEFIT ANALYSIS; DECISION TREES; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MEXICO; MIDDLE AGED; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; ULTRASONOGRAPHY;

MLCS; MLOWN;

EID: 13844311268     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)32093-9     Document Type: Article

References (0)